Grameva Limited Hits All-Time High of Rs 95.48 as Momentum Builds Across Timeframes

1 hour ago
share
Share Via
Grameva Limited, a player in the Paper, Forest & Jute Products sector, reached a new milestone on 25 June 2026 as its stock price touched an all-time high of Rs.95.48. This achievement marks a significant moment in the company’s market journey, reflecting strong performance and sustained upward momentum over recent periods.
Grameva Limited Hits All-Time High of Rs 95.48 as Momentum Builds Across Timeframes

Price Action and Recent Performance

The stock opened with a gap-up of 4.99% and maintained this level throughout the trading day, touching an intraday high that matched the closing price. This stability at the peak price is notable given the stock’s erratic trading history, having missed trading on one day in the last 20 sessions. The momentum is further underscored by a 15.73% return over the last three days and a striking 58.16% rise over the past three months, dwarfing the Sensex’s modest 2.82% gain in the same timeframe. Grameva Limited is trading comfortably above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day lines, signalling a robust bullish trend. The technical indicators largely support this momentum, with MACD and Bollinger Bands showing bullish signals on both weekly and monthly charts, although the RSI remains bearish on the weekly scale, suggesting some near-term caution may be warranted. Grameva Limited’s delivery volumes have surged by 237.5% over the past month, reflecting increased investor participation in the rally — is this sustained buying interest or a short-term spike?

Valuation Metrics and Market Positioning

At a price-to-earnings (P/E) ratio of 16x, Grameva Limited trades at a moderate premium relative to many micro-cap peers in the Paper, Forest & Jute Products sector. The price-to-book value stands at 3.89x, while the enterprise value to EBITDA ratio is 11.28x, indicating that the market is pricing in steady earnings growth. The EV/Sales multiple of 0.63x and EV/Capital Employed of 2.67x suggest reasonable asset utilisation, though the relatively high EV/EBIT of 12.41x points to stretched operating profitability multiples. The absence of dividend payouts aligns with the company’s reinvestment strategy, but investors should note the lack of income return in the current phase. At these valuations, should you be booking profits on Grameva Limited or can the company grow into this premium?

Quarter after quarter, this Small Cap from the Lifestyle sector delivers without fail! Just added to our Reliable Performers with proven staying power. Stability meets growth here beautifully.

  • - Consistent quarterly delivery
  • - Proven staying power
  • - Stability with growth

See the Consistent Performer →

Financial Trend and Profitability

The recent quarterly financials reveal an outstanding turnaround, with profit before tax excluding other income soaring by 5100% to ₹3.75 crores compared to the previous four-quarter average. Net sales for the latest six months have risen to ₹68.25 crores, accompanied by a PAT of ₹2.72 crores, both reflecting solid top-line and bottom-line growth. The half-year ROCE has reached a peak of 23.03%, a significant improvement over the company’s historical average of 5.58%, indicating enhanced capital efficiency. Earnings per share for the quarter stand at ₹5.48, the highest recorded, reinforcing the strength of recent operational performance. Does this financial momentum signal a sustainable shift or a temporary spike?

Quality Metrics and Capital Structure

Despite the recent financial upswing, Grameva Limited is classified as a below-average quality company based on long-term financial performance. The five-year sales and EBIT growth rates of 32.56% and 38.25% respectively demonstrate healthy expansion, yet the average EBIT to interest coverage ratio of 1.24x points to relatively weak earnings protection against debt costs. The company carries a moderate net debt-to-equity ratio of 0.73 and a high debt-to-EBITDA ratio of 4.64, indicating leverage that could constrain flexibility. Return on equity and capital employed remain subdued at 7.50% and 5.58%, respectively, suggesting that while growth is robust, capital efficiency and profitability have room for improvement. Notably, there is no promoter share pledging, which reduces governance risk. How do these quality factors weigh against the recent price surge?

Technical Indicators and Market Sentiment

The technical landscape for Grameva Limited is predominantly bullish. Weekly and monthly MACD and Bollinger Bands indicators align positively, supporting the current uptrend. The stock’s position above all major moving averages further confirms strong upward momentum. However, the weekly RSI is bearish, hinting at potential short-term overbought conditions. Dow Theory presents a mixed picture with mildly bearish weekly signals but bullish monthly trends, while the KST indicator is bullish weekly but mildly bearish monthly. On-balance volume (OBV) trends mildly bullish, indicating that volume supports price advances. The immediate support level remains at the 52-week low of ₹29.57, while the 20-day moving average near ₹80.42 previously acted as resistance but has now been decisively breached. Is the technical momentum robust enough to sustain this rally or is a correction imminent?

Why settle for Grameva Limited? SwitchER evaluates this Paper, Forest & Jute Products micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!

  • - Comprehensive evaluation done
  • - Superior opportunities identified
  • - Smart switching enabled

Discover Superior Stocks →

Key Data at a Glance

Current Price
Rs 95.48
52-Week Range
Rs 29.57 - 95.48
P/E Ratio (TTM)
16x
Price to Book Value
3.89x
EV/EBITDA
11.28x
ROCE (Half Year)
23.03%
5-Year Sales Growth
32.56%
Debt to EBITDA
4.64x

Balancing the Bull and Bear Cases

Grameva Limited’s ascent to an all-time high is backed by strong recent financial performance and a technical setup that favours continuation. The impressive quarterly profit growth and elevated ROCE mark a positive shift in operational efficiency. However, the company’s below-average quality metrics, particularly its leverage and modest returns on equity, temper the enthusiasm. Valuation multiples are reasonable but not undemanding, especially given the micro-cap status and sector volatility. The weekly bearish RSI and mixed Dow Theory signals suggest that while momentum is supportive, some consolidation or profit booking could occur. Should you buy, sell, or hold? With momentum and valuations pulling in opposite directions, no single data point tells the full story — see the complete multi-factor analysis of Grameva Limited to find out.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News